Sana Biotechnology, Inc.
SANA
$3.55
-$0.12-3.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -15.88% | -25.28% | -30.83% | -26.88% | -26.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.26% | -16.21% | -29.66% | -35.91% | -30.33% |
| Operating Income | 10.26% | 16.21% | 29.66% | 35.91% | 30.33% |
| Income Before Tax | 16.00% | -15.96% | 8.47% | 23.35% | -2.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.00% | -15.96% | 8.47% | 23.35% | -2.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.00% | -15.96% | 8.47% | 23.35% | -2.97% |
| EBIT | 10.26% | 16.21% | 29.66% | 35.91% | 30.33% |
| EBITDA | 9.21% | 15.50% | 30.38% | 37.08% | 31.38% |
| EPS Basic | 28.47% | -6.14% | 16.65% | 31.16% | 7.58% |
| Normalized Basic EPS | 23.18% | 25.21% | 36.86% | 44.23% | 39.67% |
| EPS Diluted | 28.47% | -6.14% | 16.65% | 31.16% | 7.59% |
| Normalized Diluted EPS | 23.18% | 25.21% | 36.86% | 44.23% | 39.45% |
| Average Basic Shares Outstanding | 17.01% | 11.43% | 9.63% | 9.99% | 12.02% |
| Average Diluted Shares Outstanding | 17.01% | 11.43% | 9.63% | 9.99% | 11.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |